Cargando…

Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer

Some patients with differentiated thyroid cancer (DTC) may require an initial low dose (LD) of lenvatinib. However, few studies have investigated the efficacy of LD lenvatinib. We compared the efficacy and tolerability of lenvatinib at an initial LD to those of the standard initial dose of 24 mg in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Haruhiko, Iwasaki, Hiroyuki, Takasaki, Hirotaka, Suganuma, Nobuyasu, Sakai, Rika, Masudo, Katsuhiko, Nakayama, Hirotaka, Rino, Yasushi, Masuda, Munetaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6417556/ https://www.ncbi.nlm.nih.gov/pubmed/30855484 http://dx.doi.org/10.1097/MD.0000000000014774

Ejemplares similares

Anaplastic thyroid carcinoma diagnosed after treatment of lenvatinib for papillary thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

A Case of Pneumothorax after Treatment with Lenvatinib for Anaplastic Thyroid Cancer with Lung Metastasis
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Two cases of thyroid gland invasion by upper mediastinal carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2019)

Renal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors: A retrospective study
por: Iwasaki, Hiroyuki, et al.
Publicado: (2019)

Invasive procedures in patients undergoing treatment with lenvatinib for thyroid cancer
por: Toda, Soji, et al.
Publicado: (2021)

Lenvatinib vs. palliative therapy for stage IVC anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Pneumatosis intestinalis associated with lenvatinib during thyroid cancer treatment: a case report
por: Toda, Soji, et al.
Publicado: (2021)

A Large Substernal Goiter that Extended to Both Sides of the Thorax
por: Nakayama, Hirotaka, et al.
Publicado: (2018)

Occult Thyroid Carcinoma without Malignant Thyroid Gland Findings during Preoperative Examination: Report of Three Cases
por: Toda, Soji, et al.
Publicado: (2020)

Nephrectomy for Metastatic Kidney Tumor in Patients with Differentiated Thyroid Cancer: A Report of Two Cases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Chest wall resection and reconstruction using titanium micromesh covered with Marlex mesh for metastatic follicular thyroid carcinoma: a case report
por: Suganuma, Nobuyasu, et al.
Publicado: (2009)

Conversion surgery after lenvatinib treatment for anaplastic thyroid carcinoma: a case report
por: Yamazaki, Haruhiko, et al.
Publicado: (2023)

Non-functioning parathyroid carcinoma: a case report
por: Suganuma, Nobuyasu, et al.
Publicado: (2017)

Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
por: Iwasaki, Hiroyuki, et al.
Publicado: (2023)

Superior vena cava (SVC) reconstruction using autologous tissue in two cases of differentiated thyroid carcinoma presenting with SVC syndrome
por: Wada, Nobuyuki, et al.
Publicado: (2009)

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions
por: Inari, Hitoshi, et al.
Publicado: (2017)

A case of undifferentiated pleomorphic sarcoma of the breast with lung and bone metastases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Lenvatinib and selpercatinib successfully treated RET fusion gene-positive papillary thyroid carcinoma cardiac metastases: a case report
por: Toda, Soji, et al.
Publicado: (2023)

Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
por: Yamazaki, Haruhiko, et al.
Publicado: (2020)

Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid Carcinoma
por: Onoda, Naoyoshi, et al.
Publicado: (2020)

Deltopectoral flap revisited for reconstruction surgery in patients with advanced thyroid cancer: a case report
por: Mikami, Taro, et al.
Publicado: (2017)

THU510 The Frequency Of Mutations In Advanced Thyroid Cancer In Japan: A Real Clinical Setting
por: Toda, Soji, et al.
Publicado: (2023)

TROP-2, Nectin-4, GPNMB, and B7-H3 Are Potentially Therapeutic Targets for Anaplastic Thyroid Carcinoma
por: Toda, Soji, et al.
Publicado: (2022)

Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival
por: Wada, Nobuyuki, et al.
Publicado: (2009)

Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection
por: Toyoda, Madoka, et al.
Publicado: (2022)

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
por: Suyama, Koichi, et al.
Publicado: (2017)

Three Cases of Anaplastic Thyroid Carcinoma Transformation and Leukocytosis during Lenvatinib Treatment
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Left parathyroid carcinoma with secondary hyperparathyroidism: a case report
por: Yokoyama, Ko, et al.
Publicado: (2023)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Rechallenge with Lenvatinib after Refractoriness to Initial Lenvatinib Followed by Sorafenib in a Patient with Metastatic Papillary Thyroid Carcinoma
por: Takinami, Masaki, et al.
Publicado: (2020)

Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers
por: Suyama, Koichi, et al.
Publicado: (2018)

Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
por: Iwasaki, Hiroyuki, et al.
Publicado: (2021)

Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
por: Masaki, Chie, et al.
Publicado: (2021)

Phase II Study of S-1 Monotherapy as a First-line, Combination Therapy of S-1 plus Cisplatin as a Second-line, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: Phase II Study of S-1, S-1 plus Cisplatin, and Weekly Paclitaxel in Patients with Advanced Gastric Carcinoma
por: Rino, Yasushi, et al.
Publicado: (2008)

Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events
por: Iwamoto, Hideki, et al.
Publicado: (2020)

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
por: Isaka, Tetsuya, et al.
Publicado: (2018)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
por: Tsuchiya, Kaoru, et al.
Publicado: (2021)

Exploratory Analysis to Predict Optimal Tumor Burden for Starting Lenvatinib in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
por: Suzuki, Chiaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1lgf2sm99ld235htan9ampg5s5